Fenwick intellectual property partner Carl Morales will moderate and litigation partner Ryan Johnson will serve on a panel discussing key issues related to “carve outs” and the implications of the GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. series of decisions for induced infringement of method patents.